Figures & data
Figure 1. A representative transverse slice of the CT scans acquired on 25th August (A; least pleural effusion), 8th September (B; most pleural effusion) and 2nd October (C; intermediate level of pleural effusion), which served as basis for treatment plans R1/R2A, R2C and R2B, respectively. The deviation of the contours of right lung (purple), CTV elective (red) and CTV boost (orange) with varying positions of the mediastinum can be appreciated.
![Figure 1. A representative transverse slice of the CT scans acquired on 25th August (A; least pleural effusion), 8th September (B; most pleural effusion) and 2nd October (C; intermediate level of pleural effusion), which served as basis for treatment plans R1/R2A, R2C and R2B, respectively. The deviation of the contours of right lung (purple), CTV elective (red) and CTV boost (orange) with varying positions of the mediastinum can be appreciated.](/cms/asset/79f803bc-1d96-492c-be8d-c64b3f626d94/ionc_a_1994154_f0001_c.jpg)
Table 1. Overview of the applied treatment plans and acquired control CT during the course of the plan-library-based plan-of-the-day approach.
Figure 2. The summed dose distribution of the proton beam treatment plans R1, R2A and R2B covering the high-dose clinical target volume (CTV; iCTVp_08_6600) and the elective CTV (iCTVp_5000) is shown in transverse (A), coronal (B) and sagittal (C) views. The 62 Gy(RBE) isodose line is depicted in orange. The dose-volume histogram for the summed dose is presented in (D).
![Figure 2. The summed dose distribution of the proton beam treatment plans R1, R2A and R2B covering the high-dose clinical target volume (CTV; iCTVp_08_6600) and the elective CTV (iCTVp_5000) is shown in transverse (A), coronal (B) and sagittal (C) views. The 62 Gy(RBE) isodose line is depicted in orange. The dose-volume histogram for the summed dose is presented in (D).](/cms/asset/0ca0bf97-bdcc-4fff-b702-607cc1da7ddf/ionc_a_1994154_f0002_c.jpg)